First-line therapy for metastatic renal cell carcinoma: A propensity score-matched comparison of efficacy and safetyTakafumi Yanagisawa, Takahiro Kimura, Masaya Murakami et al.|Urologic Oncology Seminars and Original Investigations|2024Cited by 7
Clinical features of medication‐related osteonecrosis of the jaw in prostate cancer managementYuma Goto, Fumihiko Urabe, Juria Nakano et al.|British Journal of Urology|2025Cited by 4
Evaluating CRPC Definition: Comparing Upfront ARSI and Conventional Hormonal Therapy for Metastatic Hormone Sensitive Prostate Cancer (mHSPC) in Real World Propensity Score Matched CohortTatsuya Shimomura, Fumihiko Urabe, Katsuki Muramoto et al.|The Prostate|2025Cited by 3
Extracellular vesicles in renal cell carcinoma: A review of the current landscape and future directionsNakanori Fujii, Koji Shiraishi, Fumihiko Urabe et al.|Urologic Oncology Seminars and Original Investigations|2025Cited by 3
Delayed-onset immune-related colitis more than three years after nivolumab therapy for metastatic renal cell carcinoma: A case reportKen Shibata, Takahiro Kimura, Fumihiko Urabe et al.|International Cancer Conference Journal|2025Cited by 1